Altium Capital Management LP Capricor Therapeutics, Inc. Transaction History
Altium Capital Management LP
- $301 Million
- Q4 2024
A detailed history of Altium Capital Management LP transactions in Capricor Therapeutics, Inc. stock. As of the latest transaction made, Altium Capital Management LP holds 714,000 shares of CAPR stock, worth $9.15 Million. This represents 3.29% of its overall portfolio holdings.
Number of Shares
714,000
Previous 285,000
150.53%
Holding current value
$9.15 Million
Previous $4.33 Million
128.15%
% of portfolio
3.29%
Previous 1.53%
Shares
2 transactions
Others Institutions Holding CAPR
# of Institutions
133Shares Held
16MCall Options Held
1.73MPut Options Held
1.71M-
Vanguard Group Inc Valley Forge, PA2.28MShares$29.2 Million0.0% of portfolio
-
Farallon Capital Management LLC San Francisco, CA2.25MShares$28.8 Million0.17% of portfolio
-
State Street Corp Boston, MA2.21MShares$28.3 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.63MShares$20.9 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA879KShares$11.3 Million0.0% of portfolio
About CAPRICOR THERAPEUTICS, INC.
- Ticker CAPR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,346,200
- Market Cap $312M
- Description
- Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for th...